- First quarter gross margin expanded 80 basis points to
32.3%
- Operating income increased 6% to $12.1 million with a margin of
8.2%, which was up 40 basis points
- Net income per diluted share increased 8% to $0.42; Adjusted
net income per share was $0.58, up 5%
- Generated $9.2 million of cash from operations, more than
double last year’s first quarter
Allient Inc. (Nasdaq: ALNT) (“Allient” or the “Company”), a
global designer and manufacturer of precision and specialty Motion,
Controls and Power products and solutions for targeted industries
and applications, today reported financial results for its first
quarter ended March 31, 2024. Results include the acquisitions of
Sierramotion Inc. in September 2023 and SNC Manufacturing in
January 2024.
Dick Warzala, Chairman and CEO, commented, “Our first quarter
performance is a testament to the resilience of our diversified
business portfolio across various regions. Moreover, our commitment
to operational excellence and cost management has bolstered our
margins and fueled bottom-line growth along with strong cash flow
generation. Given improved lead times, customer order patterns are
normalizing to a pre-pandemic environment and excess supply is
being taken out of the channel, which has had an impact on order
rates. Currently, demand from our end markets is mixed, reflecting
the various states of supply normalization within each market, with
some pockets of weakness in Europe.”
Mr. Warzala added, “With the introduction of our new strategic
mantra, Simplify to Accelerate NOW, we are embarking on a journey
to streamline our organizational structure and excising redundancy
to optimize all of our operations. By consolidating our brands
under the banners of Motion, Controls, and Power, we will ensure a
unified approach, enhance clarity in the market, and more
effectively serve our diverse global customers.
“In pursuit of sustained earnings growth and additional cash
generation, our teams have identified key strategic actions for
2024. These encompass footprint rationalization, simplification of
customer interactions and order processing, reduction of product
development timelines, and the continued integration of AST, our
lean toolkit, throughout Allient. The initiatives are being phased
in with initial benefits to be realized in 2024 and continuing for
the next 2+ years, supporting our margin expansion in line with our
previously stated goal of 100 total basis point annual improvement
via gross margin expansion and operating expense reduction. Guided
by our mantra and fueled by strategic foresight, we are poised to
seize new opportunities, drive operational excellence, and deliver
value to our stakeholders."
First Quarter 2024 Results (Narrative compares with
prior-year period unless otherwise noted)
Revenue increased 1%, or $1.2 million, to $146.7 million. The
impact of foreign currency exchange rate fluctuations was favorable
by $0.2 million. Sales to U.S. customers were 58% of total sales
compared with 56% in the first quarter last year, with the balance
of sales to customers primarily in Europe, Canada and Asia-Pacific.
See the attached table for a description of non-GAAP financial
measures and reconciliation of revenue excluding foreign currency
exchange rate fluctuations.
Sales in the Vehicle markets increased 12% due to higher demand
within commercial automotive, partially offset by lower demand
within agricultural vehicles, which primarily reflected softness in
Europe, largely influenced by the Ukrainian conflict. Industrial
markets sales were up 10% in the quarter, benefiting from recent
acquisitions and higher end market demand within industrial
automation, electronics and power quality solutions focused on the
HVAC markets. Aerospace & Defense sales decreased 22%, largely
due to program timing within the space industry. Medical market
revenue was down 19% given softer medical mobility demand. Sales
through the Distribution channel, which are a small component of
total sales, were up 3%.
Gross margin was 32.3%, up 80 basis points from the prior-year
period as higher volume, favorable mix and pricing more than offset
elevated raw material costs.
Operating costs and expenses were 24.0% of revenue, up 30 basis
points, largely due to higher engineering and business development
expenses as a result of the recent acquisitions, partially offset
by lower general and administrative costs. Operating income
increased 6% to $12.1 million, or 8.2% of revenue, compared with
$11.4 million, or 7.8% of revenue.
The effective income tax rate was 21.8% and 23.2% for the first
quarter of 2024 and 2023, respectively. The lower effective tax
rate in the first quarter of 2024 was primarily due to the
realization of certain deferred income tax assets that had been
reserved in prior years, as well as the impact of the mix of
foreign and domestic income. The Company expects its income tax
rate for the full year 2024 to be approximately 21% to 23%.
Net income increased 9% to $6.9 million, or $0.42 per diluted
share, from $6.3 million, or $0.39 per diluted share, in the
prior-year period. Adjusted net income, which excludes amortization
of intangible assets related to acquisitions, business development
costs and other non-recurring items, increased 7% to $9.5 million,
or $0.58 per diluted share, compared with adjusted net income of
$8.9 million, or $0.55 per diluted share. See the attached tables
for a description of non-GAAP financial measures and reconciliation
table for Adjusted Net Income and Diluted Earnings per Share.
Earnings before interest, taxes, depreciation, amortization,
stock-based compensation expense, business development costs, and
foreign currency gains/losses (“Adjusted EBITDA”) was $20.0
million, up $1.0 million or 5%. As a percentage of revenue,
Adjusted EBITDA was 13.7%, up 60 basis points. The Company believes
that, when used in conjunction with measures prepared in accordance
with U.S. generally accepted accounting principles, Adjusted
EBITDA, which is a non-GAAP measure, helps in the understanding of
its operating performance. See the attached table for a description
of non-GAAP financial measures and reconciliation table for
Adjusted EBITDA.
Balance Sheet and Cash Flow Review
Cash and cash equivalents were $31.5 million compared with $31.9
million at year-end 2023. Cash provided by operating activities
increased to $9.2 million compared with $3.6 million in the prior
year’s first quarter, which reflected higher net income and
improved working capital.
Capital expenditures were $3.0 million for the quarter and
largely focused on new customer projects. The Company expects 2024
capital expenditures to be in the range of $13 million to $17
million. The increase in cash used in investing activities in the
first quarter of 2024 relates to $20 million in cash paid for the
acquisition of SNC. Also included in investing activities for the
first quarters of 2024 and 2023, was a deferred payment of $6.25
million for a prior acquisition.
On March 1, 2024, the Company extended the maturity of its
existing $280 million revolving credit facility for five years to
March 2029. Borrowings for the revolving facility will bear
interest on a sliding-scale rate based on leverage of 1.25% to
2.50% over SOFR. In addition, the Company entered into a $150
million fixed-rate private shelf facility under which $50.0 million
of borrowings occurred on March 21, 2024. The fix-rate debt will
bear interest at 5.96% and will mature on March 21, 2031.
Total debt of $240.2 million was up $21.8 million from year-end
2023, largely reflecting the SNC acquisition. Debt, net of cash,
was $208.7 million, or 43.9% of net debt to capitalization. The
Company’s leverage ratio, as defined in its credit agreement, was
2.89x at quarter-end.
Orders and Backlog Summary ($ in thousands)
Q1
2024
Q4
2023
Q3
2023
Q2
2023
Q1
2023
Orders
$
122,127
$
105,162
$
154,908
$
137,008
$
123,198
Backlog
$
258,130
$
276,093
$
309,636
$
298,695
$
308,635
First quarter orders increased 16% sequentially, due to recent
acquisitions along with higher bookings for industrial automation
and power quality projects, and the ramp of new commercial
automotive programs. Foreign currency translation had a favorable
$0.3 million impact on first quarter orders compared with the
prior-year period.
The sequential decline in backlog reflects the continued
improvements within the supply chain, which has enabled the
reduction of long-lead times for industrial market projects. The
time to convert the majority of the backlog to sales is
approximately three to nine months.
Conference Call and Webcast
The Company will host a conference call and webcast on Thursday,
May 9, 2024 at 10:00 am ET. During the conference call, management
will review the financial and operating results and discuss
Allient’s corporate strategy and outlook. A question and answer
session will follow.
To listen to the live call, dial (201) 389-0920. In addition,
the webcast and slide presentation may be found at:
www.allient.com/investors.
A telephonic replay will be available from 2:00 pm ET on the day
of the call through Thursday, May 16, 2024. To listen to the
archived call, dial (412) 317-6671 and enter replay pin number
13745675 or access the webcast replay via the Company’s website. A
transcript will also be posted to the website once available.
About Allient Inc.
Allient (Nasdaq: ALNT) is a global engineering and manufacturing
enterprise that develops solutions to drive the future of
market-moving industries, including medical, life sciences,
aerospace and defense, industrial automation, robotics,
semi-conductor, transportation, agriculture, construction and
facility infrastructure. A family of globally responsible
companies, Allient takes a One-Team approach to “Connect What
Matters” and provides the most robust, reliable, and high-value
products and systems by utilizing its core Motion, Controls, and
Power technologies and platforms.
Headquartered in Buffalo, N.Y., Allient employs more than 2,600
team members around the world. To learn more, visit
www.allient.com.
Safe Harbor Statement
The statements in this news release that relate to future plans,
events or performance are “forward-looking statements” within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include, without limitation, any
statement that may predict, forecast, indicate, or imply future
results, performance, or achievements. Examples of forward-looking
statements include, among others, statements the Company makes
regarding expected operating results, anticipated levels of capital
expenditures, the Company’s belief that it has sufficient liquidity
to fund its business operations, and expectations with respect to
the conversion of backlog to sales. Forward-looking statements are
neither historical facts nor assurances of future performance.
Instead, they are based only on the Company’s current beliefs,
expectations and assumptions regarding the future of the Company’s
business, future plans and strategies, projections, anticipated
events and trends, the economy and other future conditions. Because
forward-looking statements relate to the future, they are subject
to inherent uncertainties, risks and changes in circumstances that
are difficult to predict and many of which are outside of the
Company’s control. The Company’s actual results and financial
condition may differ materially from those indicated in the
forward-looking statements. Therefore, you should not rely on any
of these forward-looking statements. Important factors that could
cause our actual results and financial condition to differ
materially from those indicated in the forward-looking statements
include, among others, general economic and business conditions,
conditions affecting the industries served by the Company and its
subsidiaries, conditions affecting the Company's customers and
suppliers, competitor responses to the Company's products and
services, the overall market acceptance of such products and
services, the pace of bookings relative to shipments, the ability
to expand into new markets and geographic regions, the success in
acquiring new business, the impact of changes in income tax rates
or policies, commercial activity and demand across our and our
customers’ businesses, global supply chains, the prices of our
securities and the achievement of our strategic objectives, the
ability to attract and retain qualified personnel, the ability to
successfully integrate an acquired business into our business model
without substantial costs, delays, or problems, and other factors
disclosed in the Company's periodic reports filed with the
Securities and Exchange Commission. Any forward-looking statement
speaks only as of the date on which it is made. New risks and
uncertainties arise over time, and it is not possible for us to
predict the occurrence of those matters or the manner in which they
may affect us. The Company has no obligation or intent to release
publicly any revisions to any forward looking statements, whether
as a result of new information, future events, or otherwise.
FINANCIAL TABLES FOLLOW
ALLIENT INC.
CONDENSED CONSOLIDATED
STATEMENTS OF INCOME
(In thousands, except per
share data)
(Unaudited)
For the three months
ended
March 31,
2024
2023
Revenue
$
146,713
$
145,549
Cost of goods sold
99,336
99,715
Gross profit
47,377
45,834
Operating costs and expenses:
Selling
6,298
6,032
General and administrative
14,440
14,820
Engineering and development
11,067
10,387
Business development
357
197
Amortization of intangible assets
3,115
3,009
Total operating costs and expenses
35,277
34,445
Operating income
12,100
11,389
Other expense, net:
Interest expense
3,388
2,983
Other (income) expense, net
(109
)
187
Total other expense, net
3,279
3,170
Income before income taxes
8,821
8,219
Income tax provision
(1,919
)
(1,904
)
Net income
$
6,902
$
6,315
Basic earnings per share:
Earnings per share
$
0.42
$
0.40
Basic weighted average common shares
16,394
15,872
Diluted earnings per share:
Earnings per share
$
0.42
$
0.39
Diluted weighted average common shares
16,497
16,137
ALLIENT INC.
CONDENSED CONSOLIDATED BALANCE
SHEETS
(In thousands, except per
share data)
(Unaudited)
March 31,
December 31,
2024
2023
Assets
Current assets:
Cash and cash equivalents
$
31,514
$
31,901
Trade receivables, net of provision for
credit losses of $1,165 and $1,240 at March 31, 2024 and December
31, 2023, respectively
87,905
85,127
Inventories
124,909
117,686
Prepaid expenses and other assets
15,646
13,437
Total current assets
259,974
248,151
Property, plant, and equipment, net
70,349
67,463
Deferred income taxes
7,132
7,760
Intangible assets, net
110,236
111,373
Goodwill
133,159
131,338
Operating lease assets
22,911
24,032
Other long-term assets
7,838
7,425
Total Assets
$
611,599
$
597,542
Liabilities and Stockholders’
Equity
Current liabilities:
Accounts payable
$
38,961
$
39,129
Accrued liabilities
34,147
56,488
Total current liabilities
73,108
95,617
Long-term debt
240,176
218,402
Deferred income taxes
4,760
4,337
Pension and post-retirement
obligations
2,781
2,679
Operating lease liabilities
18,478
19,532
Other long-term liabilities
5,166
5,400
Total liabilities
344,469
345,967
Stockholders’ Equity:
Common stock, no par value, authorized
50,000 shares; 16,906 and 16,308 shares issued and outstanding at
March 31, 2024 and December 31, 2023, respectively
109,576
95,937
Preferred stock, par value $1.00 per
share, authorized 5,000 shares; no shares issued or outstanding
—
—
Retained earnings
172,215
165,813
Accumulated other comprehensive loss
(14,661
)
(10,175
)
Total stockholders’ equity
267,130
251,575
Total Liabilities and Stockholders’
Equity
$
611,599
$
597,542
ALLIENT INC.
CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
For the three months
ended
March 31,
2024
2023
Cash Flows From Operating
Activities:
Net income
$
6,902
$
6,315
Adjustments to reconcile net income to net
cash provided by operating activities
Depreciation and amortization
6,385
6,145
Deferred income taxes
297
(290
)
Stock-based compensation expense
1,211
1,267
Debt issue cost amortization recorded in
interest expense
156
75
Other
411
395
Changes in operating assets and
liabilities, net of acquisitions:
Trade receivables
(292
)
(10,587
)
Inventories
(119
)
1,340
Prepaid expenses and other assets
(1,236
)
(1,115
)
Accounts payable
(2,022
)
1,548
Accrued liabilities
(2,514
)
(1,507
)
Net cash provided by operating
activities
9,179
3,586
Cash Flows From Investing
Activities:
Consideration paid for acquisitions, net
of cash acquired
(25,527
)
(6,250
)
Purchase of property and equipment
(2,973
)
(3,554
)
Net cash used in investing activities
(28,500
)
(9,804
)
Cash Flows From Financing
Activities:
Proceeds from issuance of long-term
debt
76,850
4,000
Principal payments of long-term debt and
finance lease obligations
(53,230
)
(3,116
)
Payment of contingent consideration
(2,450
)
—
Payment of debt issuance costs
(1,532
)
—
Tax withholdings related to net share
settlements of restricted stock
(100
)
(146
)
Net cash provided by financing
activities
19,538
738
Effect of foreign exchange rate changes on
cash
(604
)
11
Net decrease in cash and cash
equivalents
(387
)
(5,469
)
Cash and cash equivalents at beginning of
period
31,901
30,614
Cash and cash equivalents at end of
period
$
31,514
$
25,145
ALLIENT INC. Reconciliation of
Non-GAAP Financial Measures (In thousands)
(Unaudited)
In addition to reporting revenue and net income, which are U.S.
generally accepted accounting principle (“GAAP”) measures, the
Company presents Revenue excluding foreign currency exchange rate
impacts, and EBITDA and Adjusted EBITDA (earnings before interest,
income taxes, depreciation and amortization, stock-based
compensation expense, business development costs, and foreign
currency gains/losses), which are non-GAAP measures.
The Company believes that Revenue excluding foreign currency
exchange rate impacts is a useful measure in analyzing organic
sales results. The Company excludes the effect of currency
translation from revenue for this measure because currency
translation is not fully under management’s control, is subject to
volatility and can obscure underlying business trends. The portion
of revenue attributable to currency translation is calculated as
the difference between the current period revenue and the current
period revenue after applying foreign exchange rates from the prior
period. Organic revenue is reported revenues adjusted for the
impact of foreign currency and the revenue contribution from
acquisitions.
The Company believes EBITDA and Adjusted EBITDA are often a
useful measure of a Company’s operating performance and are a
significant basis used by the Company’s management to evaluate and
compare the core operating performance of its business from period
to period by removing the impact of the capital structure
(interest), tangible and intangible asset base (depreciation and
amortization), taxes, stock-based compensation expense, business
development costs, foreign currency gains/losses on short-term
assets and liabilities, and other items that are not indicative of
the Company’s core operating performance. EBITDA and Adjusted
EBITDA do not represent and should not be considered as an
alternative to net income, operating income, net cash provided by
operating activities or any other measure for determining operating
performance or liquidity that is calculated in accordance with
GAAP.
The Company’s calculation of Revenue excluding foreign currency
exchange impacts for the three months ended March 31, 2024 is as
follows:
Three Months Ended
March 31, 2024
Revenue as reported
$
146,713
Foreign currency impact
(238
)
Revenue excluding foreign currency
exchange impacts
$
146,475
The Company’s calculation of organic revenue for the three
months ended March 31, 2024 is as follows:
Three Months Ended
March 31, 2024
Revenue increase year over year
0.8
%
Less: Impact of acquisitions and foreign
currency
6.7
%
Organic revenue
(5.9
)%
The Company’s calculation of Adjusted EBITDA for the three
months ended March 31, 2024 and 2023 is as follows:
Three Months Ended
March 31,
2024
2023
Net income
$
6,902
$
6,315
Interest expense
3,388
2,983
Provision for income tax
1,919
1,904
Depreciation and amortization
6,385
6,145
EBITDA
18,594
17,347
Stock-based compensation expense
1,211
1,267
Foreign currency (gain) loss
(120
)
214
Business development costs
357
197
Adjusted EBITDA
$
20,042
$
19,025
ALLIENT INC. Reconciliation of GAAP
Net Income and Diluted Earnings per Share to Non-GAAP
Adjusted Net Income and Adjusted Diluted Earnings per Share
(In thousands, except per share data) (Unaudited)
The Company’s calculation of Adjusted net income and Adjusted
diluted earnings per share for the three months ended March 31,
2024 and 2023 is as follows:
For the three months
ended
March 31,
Per diluted
Per diluted
2024
share
2023
share
Net income as reported
$
6,902
$
0.42
$
6,315
$
0.39
Non-GAAP adjustments, net of tax (1)
Amortization of intangible assets –
net
2,463
0.15
2,305
0.14
Foreign currency (gain) loss – net
(92
)
(0.01
)
164
0.01
Business development costs – net
273
0.02
151
0.01
Non-GAAP adjusted net income and adjusted
diluted earnings per share
$
9,546
$
0.58
$
8,935
$
0.55
Weighted average diluted shares
outstanding
16,497
16,137
____________________________
(1) Applies a blended federal, state, and foreign tax rate of 23%
applicable to the non-GAAP adjustments.
Adjusted net income and diluted EPS are defined as net income as
reported, adjusted for certain items, including amortization of
intangible assets and unusual non-recurring items. Adjusted net
income and diluted EPS are not a measure determined in accordance
with GAAP in the United States, and may not be comparable to the
measure as used by other companies. Nevertheless, the Company
believes that providing non-GAAP information, such as adjusted net
income and diluted EPS are important for investors and other
readers of the Company’s financial statements and assists in
understanding the comparison of the current quarter’s and current
year’s net income and diluted EPS to the historical periods’ net
income and diluted EPS.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240508112647/en/
Investor Contacts: Deborah K. Pawlowski / Craig P.
Mychajluk Kei Advisors LLC 716-843-3908 / 716-843-3832
dpawlowski@keiadvisors.com / cmychajluk@keiadvisors.com
Allient (NASDAQ:ALNT)
Historical Stock Chart
From Dec 2024 to Jan 2025
Allient (NASDAQ:ALNT)
Historical Stock Chart
From Jan 2024 to Jan 2025